Omnilux Press
®
The Eyewear Forum
Quest Vision’s president Michael Walach has been granted a new efficacy patent for their Broadview Natural Addition Lens (NAL®). Their new free-form multifocal NAL® is unique in that it gives single vision like viewing experience with the performance of a multifocal lens and does not require the Fitting Height value.
QLDS software uses the VCA Lens Design Communication protocol for communicating with Laboratory Management Systems (LMS). QLDS is the exclusive provider of the NAL® technology, licensing digital free-form labs worldwide.
BestNewGlasses.com
ANNA P. 10/30/2021 AT 05:44
I was really skeptical about this OmniLux lens, which promised “continuous, sharp, natural vision at any gaze from distance to near without waves or distortions. There is no adaptation period.” I had tried progressive lens twice, and each time had to abandon it because I wasn’t able to adapt. I finally had to settle on ‘occupational computer lens’ which would allow me to see intermediate to near distant.
All I can say is ‘Wow!!’. I’m a believer. These lens are amazing. More importantly, I don’t have to painfully look for that ‘sweet spot’ for intermediate vision. I sent in my existing Charmant rimless frame to have these OmniLux lens mounted on. The final product was nothing short of exceptional. From the time I sent in my frame to the time I received it back, it was exactly 2 weeks, even though they had to customize my lens shape, which was different from the demo lens on the frame. Lastly, the cost of this amazing lens was still over $100 cheaper than the progressive I paid at my local optical store. This will be the only place I will get my lens going forward. Highly recommended.
The Optical Journal
January 18, 2022
OmniLux Lens Granted Patent
Michael Walach, the President of Quest Vision Care Specialty Lab and the CEO of QLDS, a cloud-based digital lens design global provider, holder of several US and international utility patents in the field of ophthalmic lenses and lens technology, has been granted a new, Broadview Natural Addition Lens (NAL®) efficacy patent number U.S. 11,126,012.
New Zealand Optics
March 7, 2022
US-based digital lens design company QLDS has developed Omnilux, a novel, natural accommodation multifocal spectacle lens the company says requires no fitting-height measurement or adaptation period.
Announcing the new free-form multifocal technology patent, lens designer Michael Walach, president of Quest Vision Care Specialty Lab and QLDS CEO, said the Omnilux lens was developed using QLDS’ natural addition lens (NAL) ergonomic model. “After more than half a century and hundreds of design patents and free-form technology advancements based on Bernard Maitenaz’s progressive addition lens (PAL) utility patent, a fresh multifocal lens concept is here.”
Florida-based Walach told NZ Optics the reasons behind the lens’ genesis. “I didn’t want to do another multifocal PAL. Your first pair of progressives will likely make you feel nauseous and you’ll be told to get used to them over five to 10 days, during which time you’ll learn to navigate by adjusting your gaze to the progressive corridor. Around 80% of people get used to them – some will love them, others will tolerate them – but 20% will give up on them.”
MAFO Optics
Ophthalmic Labs & Industries
Jan 4, 2022
Fitting heigh value not required: innovative multifocal NAL has been patented
Michael Walach, the President of Quest Vision Care Specialty Lab and the CEO of QLDS, a cloud based digital lens design global provider, holder of several US and international utility patents in the field of ophthalmic lenses and lens technology, has been granted a new, Broadview Natural Addition Lens (NAL) efficacy patent number U.S. 11,126,012.
The new free-form multifocal NAL is unique in that it gives single vision like viewing experience with the performance of a multifocal lens and does not require the Fitting Height value.
Vision Monday
November 12, 2021
U.S. Patent Issued for New Multifocal Spectacle Lens Designed by Michael Walach
The NAL design is being commercialized in the Omnilux lens. “The Omnilux lens was developed utilizing the NAL eye-lens ergonomic model,” explained Walach. “It is a significant improvement over a PAL (progressive addition lens) mainly in that the adaptation period is not required, and no fitting height measurement is needed when dispensing or ordering. In the lab it is edged and inspected just like a single vision lens, which improves production efficiency, reduces costly redos, and increases patient viewing comfort.”